SEC Form 4 · accession 0001140361-15-032984
OMNICARE INC · OCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Amy Wallman
Director
Period of report
May 28, 2015
Accepted (ET)
Aug 20, 2015 · 5:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000353230
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 28, 2015 | G | 14,840 | $0.00 | D | 21,076 | D | |
| Common StockF1 | Aug 18, 2015 | D | 21,076 | $98.00 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF2 | $26.56 | Aug 18, 2015 | D | 1,506 | D | May 7, 2013 | May 6, 2019 | Common Stock | 1,506 | 0 | D |
| Stock OptionF2 | $27.70 | Aug 18, 2015 | D | 1,498 | D | May 6, 2014 | May 5, 2020 | Common Stock | 1,498 | 0 | D |
| Stock OptionF2 | $31.20 | Aug 18, 2015 | D | 1,266 | D | May 5, 2015 | May 4, 2021 | Common Stock | 1,266 | 0 | D |
| Stock OptionF2 | $35.28 | Aug 18, 2015 | D | 1,140 | D | May 3, 2016 | May 2, 2022 | Common Stock | 1,140 | 0 | D |
| Stock OptionF2 | $43.50 | Aug 18, 2015 | D | 902 | D | May 2, 2017 | May 1, 2023 | Common Stock | 902 | 0 | D |
| Stock OptionF2 | $60.09 | Aug 18, 2015 | D | 666 | D | May 6, 2018 | May 5, 2024 | Common Stock | 666 | 0 | D |
| Stock OptionF2 | $91.01 | Aug 18, 2015 | D | 444 | D | May 8, 2019 | May 7, 2025 | Common Stock | 444 | 0 | D |
Explanation of responses
- F1At the Effective Time (as defined in the Agreement and Plan of Merger, dated May 20, 2015 (the "Merger Agreement"), by and among the Company, CVS Pharmacy, Inc. and Tree Merger Sub, Inc.), these shares of Common Stock were converted into the right to receive the merger consideration of $98.00 per share in cash (the "Merger Consideration") in accordance with the Merger Agreement.
- F2At the Effective Time, in accordance with the Merger Agreement, this stock option acquired under the Omnicare StockPlus Program (broad-based stock purchase/option plan) became fully vested and was cancelled and converted into the right to receive a cash amount determined by multiplying (x) the excess of the Merger Consideration over the exercise price of such stock option by (y) the number of shares of Common Stock subject to such stock option.